GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,160.00
+5.00 (0.16%)
At close: Mar 28, 2025, 3:30 PM KST
-23.95%
Market Cap 27.21B
Revenue (ttm) 82.96B
Net Income (ttm) 2.87B
Shares Out 8.61M
EPS (ttm) 333.00
PE Ratio 9.49
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,466
Average Volume 25,514
Open 3,230.00
Previous Close 3,155.00
Day's Range 3,145.00 - 3,235.00
52-Week Range 3,020.00 - 4,410.00
Beta 0.51
RSI 41.89
Earnings Date Mar 14, 2025

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 38
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2024, GeneBioTech Co. ,Ltd's revenue was 82.96 billion, an increase of 4.38% compared to the previous year's 79.48 billion. Earnings were 2.87 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.